Nancy Retzlaff

Corporate Officer/Principal bei Vyera Pharmaceuticals LLC

Health Technology

Consumer Services

Aktive Positionen von Nancy Retzlaff

Unternehmen	Position	Beginn	Ende
Vyera Pharmaceuticals LLC Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY.	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
Phoenixus AG Phoenixus AG Pharmaceuticals: MajorHealth Technology Phoenixus AG operates as a research-based pharmaceutical company. It develops and commercializes treatments for diseases and conditions with limited or no treatment options. The firm's products include Daraprim and Vecamyl. The company was founded by Martin Shkreli on February 24, 2015 and is headquartered in Baar, Switzerland.	Corporate Officer/Principal	-	-

University of Saskatchewan

Undergraduate Degree

International

Operativ

Corporate Officer/Principal	2
Undergraduate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	2
Phoenixus AG Phoenixus AG Pharmaceuticals: MajorHealth Technology Phoenixus AG operates as a research-based pharmaceutical company. It develops and commercializes treatments for diseases and conditions with limited or no treatment options. The firm's products include Daraprim and Vecamyl. The company was founded by Martin Shkreli on February 24, 2015 and is headquartered in Baar, Switzerland.	Health Technology
Vyera Pharmaceuticals LLC Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY.	Health Technology

Private Unternehmen

Health Technology